Wednesday, February 10, 2021 2:58:10 PM
For example, the company never promised we'll get the grant. One of the US Regional Biocontainment labs (RBL) testing Brilacidin submitted a grant with the company for further testing of Brilacidin and it was turned down.
The grant was properly submitted, but, too soon. Additional data was needed that hadn't been out yet by either of the two RBL's doing the testing. I don't know whether or not another grant submission was made yet for testing of other viruses by either of the two RBL's.
The important things are the two upcoming trials of Brilacidin against Covid and UC.
Covid trial should be starting any day if it hasn't already started.
UC trial start is something we don't know timing of yet. It may depend on results of Covid trial if he hasn't raised funds for it yet. I won't guess status other than it should be next up after covid.
Timelines... anyone here should know by now that the company is bad with time projections. But, the trials actually start at some point. Brilacidin phIII ABSSSI was an exception and that was due to funding. That trial ended up costing more than company expected along with antibiotic market changing.
Many of these timeline misses started with the severe hampering of fund raising after a series of hits by misleading and outright lying articles written in 2015 which were undoubtedly by shorting hedge funds. The price was high enough to attract shorting at that time. Anytime a stock is over $2.50 it becomes an issue. Especially in biotech.
Company adjusted by running a series of small Brilacidin trials on various indications since then. It appears to have been a move to flush out what the drug can actually do. All of those trials were later in starting than company projected, but, they all started.
My expectation is for the Covid trial to also start.
Good luck to all, whether or not you hold shares here. The world needs multiple therapeutics to work against this virus even though only a small percentage actually contract a serious case of it.
Especially, in the next year as more are vaccinated. Based on what I've been reading, those vaccinated are at risk of having much more serious disease if they catch covid down the line. Those already vaccinated must be moare careful about exposure than the unvaccinated. See Dr Fauci comments on this.
https://justthenews.com/politics-policy/coronavirus/does-influenza-vaccine-have-any-effect-other-viruses
Bottom line, I'm expecting Brilacidin Covid phII trial to start shortly if not already started.
No response needed since I'm out the door after this post is submitted.
Message in reply to:
Promises promises= the big picture.
peer review=big whoop. Is it a big splash in a big journal? Not even close. Slow to come out, in a so so journal, good for them. The preprint was the thing, as we all acknowledged at the time
Of course it is sensational for B to show success in the lab. Now for the hard work-a human trial
What about that grant Leo mentioned? And all those other viruses they were gonna test out? Not to mention MERS and SARS?
Silence. Plain and simple silence.
promises promises
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM